Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver

Journal of Biochemical and Molecular Toxicology

Volumn 17, Issue 3, 2003, Pages 169-176

  Arinç, Emel ^a   Bozcaarmutlu, Azra ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Aniline; Cimetidine; Cocaine N demethylation; Fish; Ketaconazole; Kinetics; Leaping mullet; Liver; Quinidine; SKF 525A (proadifen)

Indexed keywords

ANILINE; CIMETIDINE; COCAINE; CYTOCHROME P450 2B; CYTOCHROME P450 2D; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 REDUCTASE; FORMALDEHYDE; KETOCONAZOLE; N DEMETHYLASE; PROADIFEN; QUINIDINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME MECHANISM; FISH; IN VITRO STUDY; LIVER MICROSOME; LIVER TOXICITY; NONHUMAN;

ANIMALS; CATALYSIS; COCAINE; CYTOCHROME P-450 ENZYME SYSTEM; DEALKYLATION; ENZYME INHIBITORS; ISOENZYMES; KINETICS; LIVER; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; PROTEINS; SMEGMAMORPHA; SOLVENTS;

EID: 0038048075     PISSN: 10956670     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbt.10075     Document Type: Article

References (50)

1. Lu AYH, Levin W. The resolution and reconstitution of the liver microsomal hydroxylation system. Biochim Biophys Acta 1974;344:205-240.
2. Arinç E, Philpot RM. Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 1976;251:3213-3220.
3. Nebert DW, Gonzalez FJ. P-450 genes: Structure, evolution, and regulation. Ann Rev Biochem 1987;56:945-993.
4. Guengerich FP. Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol 1990;25:97-153.
5. Schenkman JB, Jansson I. Introduction to cytochrome P450. In: Arinç E, Hodgson E, Schenkman JB, editors. Molecular Aspects of Oxidative Drug Metabolizing Enzymes: Their Significance in Environmental Toxicology, Chemical Carcinogenesis and Health. NATO-ASI Series. New York: Springer; 1995. pp 1-19.
6. Stegeman JJ. Diversity and regulation of cytochrome P450 in aquatic species. In: Arinç E, Hodgson E, Schenkman JB, editors. Molecular Aspects of Oxidative Drug Metabolizing Enzymes: Their Significance in Environmental Toxicology, Chemical Carcinogenesis and Health. NATO-ASI Series. New York: Springer; 1995. pp 135-158.
7. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: Update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacokinetics 1996;6:1-43.
8. Newcomb M, Hollenberg PF, Coon MJ. Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations. Arch Biochem Biophys 2003;409:72-79.
9. Wringhton SA, Stevens JC. The human hepatic cytochrome P450 involved in drug metabolism. Crit Rev Toxicol 1992;22:1-22.
10. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986;315:1495-1500.
11. Evans MA, Harbison RD. Cocaine-induced hepatic necrosis in mice. Toxicol Appl Pharmacol 1978;45:739-754.
12. Thompson ML, Shuster L, Shaw K. Cocaine-induced hepatic necrosis in mice. Biochem Pharmacol 1979;28:2389-2395.
13. Perino LE, Warren GH, Levine JS. Cocaine-induced hepatotoxicity in humans. Gastroenterology 1987;93:176-180.
14. Poet TS, Mcqueen CA, Halpert JR. Participation of cytochrome P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab Dispos 1996;24:74-80.
15. Pellinen P, Stenback F, Kojo A, Honkakoski P, Gelboin HV, Pasanen M. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology 1996;23:515-523.
16. Kloss MW, Rosen GM, Rauckman EJ. N-Demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P450 and FAD-containing monooxygenase. Mol Pharmacol 1983;23:482-485.
17. LeDuc BW, Sinclair PR, Walton HS, Sinclair JF, Greenblatt DJ, Shuster L. Cocaine toxicity in cultured chicken hepatocytes: Role of cytochrome P450. Toxicol Appl Pharmacol 1994;125:322-332.
18. Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, Juvonen R. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes. Arch Toxicol 2000;74:511-520.
19. Boelsterli UA, Lanzotti AC, Goldlin C, Oertle M. Identification of cytochrome P450IIBI as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab Dispos 1992;20:96-101.
20. Poet TS, Brendel K, Halpert JR. Inactivation of cytochrome P450 2B protects against cocaine-mediated toxicity in rat liver slices. Toxicol Appl Pharmacol 1994;126:26-32.
21. Ladona MG, Gonzalez ML, Rane A, Peter RM, Torre RDL. Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P4503A expression. Life Sci 2000;68:431-443.
22. Pellinen P, Stenbach F, Raunio H, Pelkonen O, Pasanen M. Modification of hepatic cytochrome P450 profile by cocaine-induced hepatotoxicity in DBA/2 mouse. Eur J Pharmacol Env Toxicol Pharmacol 1994;292:57-65.
23. Arinç E, Adali O. Solubilization and partial purification of two forms of cytochrome P450 from trout liver microsomes. Comp Biochem Physiol 1983;76B:653-662.
24. Stegeman JJ, Kloepper-Sams PJ. Cytochrome P450 isozymes and monooxygenase activity in aquatic animals. Environ Health Perspect 1987;71:87-95.
25. Andersson T, Förlin L. Regulation of cytochrome P450 enzyme system in fish. Aquatic Toxicol 1992;24:1-20.
26. Sen A, Arinç E. Preparation of highly purified cytochrome P4501A1 from leaping mullet (Liza saliens) liver microsomes and biocatalytic, molecular and immunochemical properties. Comp Biochem Phys 1998;121C:249-265.
27. Buhler DR, Wang-Buhler J-L. Rainbow trout cytochrome P450s: Purification, molecular aspects, metabolic activity, induction and role in environmental monitoring. Comp Biochem Physiol 1998;121C:107-137.
28. Arinç E, Sen A. Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey. Mar Environ Res 1999;48:147-160.
29. Arinç E, Sen A, Bozcaarmutlu A. Cytochrome P4501A and associated mixed-function oxidase induction in fish as a biomarker for toxic carcinogenic pollutants in the aquatic environment. Pure Appl Chem 2000;72:985-994.
30. Arinç E, Kocabiyik S, Su E. Induced CYP1A mRNA, protein and catalytic activity in the liver of feral fish, leaping mullet, Liza saliens. Comp Biochem Physiol 2001;128C:281-290.
31. Sen A, Arinç E. Purification and characterization of cytochrome P450 reductase from feral leaping mullet (Liza saliens) liver microsomes. J Biochem Mol Toxicol 1998;12:103-113.
32. Sen A, Arinç E. Further immunochemical and biocatalytic characterization of CYP1A1 from feral leaping mullet liver (Liza saliens) microsomes. Comp Biochem Physiol 2000;126C:235-244.
33. Sen A, Hu CH, Urbach E, Wang-Buhler JL, Yang YH, Arinç E, Buhler DR. Cloning, sequencing and characterization of CYP1A1 cDNA from leaping mullet (Liza saliens) liver and implications for the potential functions of its conserved amino acids. J Biochem Mol Toxicol 2001;15:243-255.
34. Arinç E, Sen A. Characterization of cytochrome P450 dependent mixed function oxidase system of gilthead seabream (Sparus aurata; Sparidae) liver. Comp Biochem Physiol 1993;104B:133-139.
35. Bozcaarmutlu A. Cytochrome P4502B-Type Protein from Feral Leaping mullet (Liza saliens) Liver Microsomes: Its Isolation and Biochemical and Immunological Characterization. PhD Thesis. Turkey: Middle East Technical University Ankara; 2002. pp 1-209.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
37. Omura T, Sato R. The carbon monoxide-binding pigement of liver microsomes, II: Solubilization, purification and properties. J Biol Chem 1964;239:2379-2385.
38. Masters BSS, Williams CH, Kamin H. The preparation and properties of microsomal TPNH-cytochrome c reductase from pig liver. In: Coon MJ, Conney AH, Estabook RW, Gelboin HV, Gillette JR, O'Brien PJ, editors. Methods in Enzymology. New York: Academic Press; 1967. pp 709-720.
39. 2 and ferrocytochrome c and enzymic determination of extinction coefficients of cytochrome c. J Biol Chem 1965;210:4509-4514.
40. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 1953;55:416-421.
41. Cochin J, Alexrod J. Biochemical and pharmacological changes in the rat following chronic administration of morphine, nalmorphine and normorphine. J Pharmacol Exp Ther 1959;125:105-110.
42. Ulusoy G, Boyuneǧmez T, Bozcaarmutlu A. Kinetic and biochemical evidence suggest that at least two isoforms of P450 participates in N-demethylation of cocaine in rabbit. In: Abstract Book, XVII National Biochemistry Congress, Ankara, Turkey, June 24-27, 2002. pp 533-534.
43. Arinç E. Characterization of sheep liver and lung microsomal ethylmorphine N-demethylase. Comp Biochem Physiol 1985;80B:389-399.
44. Hickman D, Wang JP, Wang Y, Unadkat JD. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P452 monooxygenase activities. Drug Metab Dispos 1998;26:207-215.
45. Halpert JR, Guengerich FP, Bend JR, Correia MA. Contemporary issues in toxicology: Selective inhibitors of cytochrome P450. Toxicol Appl Pharmacol 1994;125:163-175.
46. Bournie M, Meunier V, Berger Y, Fabre G. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 1996;277:321-332.
47. Kasahara M, Suzuki H, Komiya I. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: Evalution of the possibility of a metabolic intermediate complex formation with CYP, and identification of human CYP isoforms. Drug Metab Dispos 2000;28:409-417.
48. Murray M. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats. Arch Biochem Biophys 1988;262:381-388.
49. Ramamoorthy Y, Yu A, Suh N, Haining RL, Tyndale RF, Sellers EM. Reduced (±)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P4502D6 inhibitors and pharmacogenetic variants in vitro. Biochem Pharmacol 2002;63:2111-2119.
50. Boyer CS, Peterson DR. Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res 1990;14:28-31.